Retrograde ejaculation occurs in the dog, but can be prevented by pre-treatment with phenylpropanolamine: A urodynamic study

Retrograde ejaculation is partial or total propulsion of semen from the posterior urethra into the urinary bladder; it is well characterized (and relatively common) in humans, with only a few reports in animals. Our objectives were to determine whether retrograde flow of semen occurred during ejacul...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Theriogenology 2008-10, Vol.70 (7), p.1057-1064
Hauptverfasser: Beaufays, F., Onclin, K., Verstegen, J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1064
container_issue 7
container_start_page 1057
container_title Theriogenology
container_volume 70
creator Beaufays, F.
Onclin, K.
Verstegen, J.
description Retrograde ejaculation is partial or total propulsion of semen from the posterior urethra into the urinary bladder; it is well characterized (and relatively common) in humans, with only a few reports in animals. Our objectives were to determine whether retrograde flow of semen occurred during ejaculation in mature dogs with normal fertility, and to determine the effects of phenylpropanolamine on this phenomenon (dose-titration, switch-back study). Retrograde ejaculation and urethral pressure profile measurements were evaluated (double-blind) in six dogs after 5 days of oral treatment with phenylpropanolamine (0, 2, 4, or 8 mg/kg); all dogs received all treatments (at 2-week intervals). The number of sperm in the urine was determined before and after each manual sperm collection. Urethral pressure profiles were obtained three times during each procedure. In the absence of phenylpropanolamine, sperm were present in the bladder after semen collection in all dogs (number varied significantly among individuals). The mean (±S.D.) number of sperm in the bladder was 17.0 ± 5.0, 18.5 ± 1.2, 5.1 ± 5.0, and 4.8 ± 0.1 × 10 6 sperm for 0, 2, 4, and 8 mg/kg, respectively (no significant difference between dogs given 4 or 8 mg/kg, but both were significantly lower than those given 0 or 2 mg/kg). This reduction was significantly correlated to the increase in mean urethral pressure at the level of the sphincter (39 cm versus 59 cm H 2O in placebo-treated dogs versus those given 8 mg/kg). In conclusion, we confirmed that retrograde ejaculation occurred during the ejaculatory process in normal dogs, and we demonstrated that phenylpropanolamine (4 or 8 mg/kg once daily for 5 days before collection) increased urethral pressure and reduced the number of sperm voided into the bladder during ejaculation.
doi_str_mv 10.1016/j.theriogenology.2008.06.026
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69552572</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0093691X08003774</els_id><sourcerecordid>69552572</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-e35afff37bb5a5213a35eb536cd0b2a8700c7f06791eea2727974c8b466d015c3</originalsourceid><addsrcrecordid>eNqNkE2LFDEQhhtR3HH1L2gO4ske8zFJumUvy-KqsCCoC95COqnuydCdtEl6pcEfb4YZEG-eiiqeqnp5quo1wVuCiXh32OY9RBcG8GEMw7qlGDdbLLaYikfVhjSyrRll5HG1wbhltWjJj4vqWUoHjDETgjytLkgjJN9xuql-f4UcwxC1BQQHbZZRZxc8CsYsMSHnUfmGbBjeom7JyGiPOkBzhAfwGSzq1mNT5wg6T2WEfrm8R_Me_DrOMcy6hNST8_AeXaMlBrv60hqU8mLX59WTXo8JXpzrZXV_--H7zaf67svHzzfXd7XZ4SbXwLju-57JruOaU8I049BxJozFHdWNxNjIHgvZEgBNJZWt3Jmm2wlhMeGGXVZvTndLop8LpKwmlwyMo_YQlqREyznlkhbw6gSaGFKK0Ks5uknHVRGsjvbVQf1rXx3tKyxUsV_WX57_LN0E9u_yWXcBXp2AXgelh-iSuv9GMWElJmvbhhXi9kRA8fHgIKpkHHgD1kUwWdng_i_LHzHCqzk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69552572</pqid></control><display><type>article</type><title>Retrograde ejaculation occurs in the dog, but can be prevented by pre-treatment with phenylpropanolamine: A urodynamic study</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Beaufays, F. ; Onclin, K. ; Verstegen, J.</creator><creatorcontrib>Beaufays, F. ; Onclin, K. ; Verstegen, J.</creatorcontrib><description>Retrograde ejaculation is partial or total propulsion of semen from the posterior urethra into the urinary bladder; it is well characterized (and relatively common) in humans, with only a few reports in animals. Our objectives were to determine whether retrograde flow of semen occurred during ejaculation in mature dogs with normal fertility, and to determine the effects of phenylpropanolamine on this phenomenon (dose-titration, switch-back study). Retrograde ejaculation and urethral pressure profile measurements were evaluated (double-blind) in six dogs after 5 days of oral treatment with phenylpropanolamine (0, 2, 4, or 8 mg/kg); all dogs received all treatments (at 2-week intervals). The number of sperm in the urine was determined before and after each manual sperm collection. Urethral pressure profiles were obtained three times during each procedure. In the absence of phenylpropanolamine, sperm were present in the bladder after semen collection in all dogs (number varied significantly among individuals). The mean (±S.D.) number of sperm in the bladder was 17.0 ± 5.0, 18.5 ± 1.2, 5.1 ± 5.0, and 4.8 ± 0.1 × 10 6 sperm for 0, 2, 4, and 8 mg/kg, respectively (no significant difference between dogs given 4 or 8 mg/kg, but both were significantly lower than those given 0 or 2 mg/kg). This reduction was significantly correlated to the increase in mean urethral pressure at the level of the sphincter (39 cm versus 59 cm H 2O in placebo-treated dogs versus those given 8 mg/kg). In conclusion, we confirmed that retrograde ejaculation occurred during the ejaculatory process in normal dogs, and we demonstrated that phenylpropanolamine (4 or 8 mg/kg once daily for 5 days before collection) increased urethral pressure and reduced the number of sperm voided into the bladder during ejaculation.</description><identifier>ISSN: 0093-691X</identifier><identifier>EISSN: 1879-3231</identifier><identifier>DOI: 10.1016/j.theriogenology.2008.06.026</identifier><identifier>PMID: 18675452</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adrenergic alpha-Agonists - pharmacology ; Animals ; bladder ; Cross-Over Studies ; Dog ; dogs ; Dogs - physiology ; dosage ; dose response ; Dose-Response Relationship, Drug ; Dose-titration study ; drugs ; ejaculation ; Ejaculation - physiology ; Male ; male fertility ; phenylpropanoids ; Phenylpropanolamine ; Phenylpropanolamine - pharmacology ; Prostate - drug effects ; Prostate - physiology ; reproductive disorders ; Retrograde ejaculation ; Spermatozoa ; urethra ; Urethra - drug effects ; Urethra - physiology ; urine ; Urodynamic ; Urodynamics - drug effects</subject><ispartof>Theriogenology, 2008-10, Vol.70 (7), p.1057-1064</ispartof><rights>2008</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-e35afff37bb5a5213a35eb536cd0b2a8700c7f06791eea2727974c8b466d015c3</citedby><cites>FETCH-LOGICAL-c408t-e35afff37bb5a5213a35eb536cd0b2a8700c7f06791eea2727974c8b466d015c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.theriogenology.2008.06.026$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18675452$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Beaufays, F.</creatorcontrib><creatorcontrib>Onclin, K.</creatorcontrib><creatorcontrib>Verstegen, J.</creatorcontrib><title>Retrograde ejaculation occurs in the dog, but can be prevented by pre-treatment with phenylpropanolamine: A urodynamic study</title><title>Theriogenology</title><addtitle>Theriogenology</addtitle><description>Retrograde ejaculation is partial or total propulsion of semen from the posterior urethra into the urinary bladder; it is well characterized (and relatively common) in humans, with only a few reports in animals. Our objectives were to determine whether retrograde flow of semen occurred during ejaculation in mature dogs with normal fertility, and to determine the effects of phenylpropanolamine on this phenomenon (dose-titration, switch-back study). Retrograde ejaculation and urethral pressure profile measurements were evaluated (double-blind) in six dogs after 5 days of oral treatment with phenylpropanolamine (0, 2, 4, or 8 mg/kg); all dogs received all treatments (at 2-week intervals). The number of sperm in the urine was determined before and after each manual sperm collection. Urethral pressure profiles were obtained three times during each procedure. In the absence of phenylpropanolamine, sperm were present in the bladder after semen collection in all dogs (number varied significantly among individuals). The mean (±S.D.) number of sperm in the bladder was 17.0 ± 5.0, 18.5 ± 1.2, 5.1 ± 5.0, and 4.8 ± 0.1 × 10 6 sperm for 0, 2, 4, and 8 mg/kg, respectively (no significant difference between dogs given 4 or 8 mg/kg, but both were significantly lower than those given 0 or 2 mg/kg). This reduction was significantly correlated to the increase in mean urethral pressure at the level of the sphincter (39 cm versus 59 cm H 2O in placebo-treated dogs versus those given 8 mg/kg). In conclusion, we confirmed that retrograde ejaculation occurred during the ejaculatory process in normal dogs, and we demonstrated that phenylpropanolamine (4 or 8 mg/kg once daily for 5 days before collection) increased urethral pressure and reduced the number of sperm voided into the bladder during ejaculation.</description><subject>Adrenergic alpha-Agonists - pharmacology</subject><subject>Animals</subject><subject>bladder</subject><subject>Cross-Over Studies</subject><subject>Dog</subject><subject>dogs</subject><subject>Dogs - physiology</subject><subject>dosage</subject><subject>dose response</subject><subject>Dose-Response Relationship, Drug</subject><subject>Dose-titration study</subject><subject>drugs</subject><subject>ejaculation</subject><subject>Ejaculation - physiology</subject><subject>Male</subject><subject>male fertility</subject><subject>phenylpropanoids</subject><subject>Phenylpropanolamine</subject><subject>Phenylpropanolamine - pharmacology</subject><subject>Prostate - drug effects</subject><subject>Prostate - physiology</subject><subject>reproductive disorders</subject><subject>Retrograde ejaculation</subject><subject>Spermatozoa</subject><subject>urethra</subject><subject>Urethra - drug effects</subject><subject>Urethra - physiology</subject><subject>urine</subject><subject>Urodynamic</subject><subject>Urodynamics - drug effects</subject><issn>0093-691X</issn><issn>1879-3231</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkE2LFDEQhhtR3HH1L2gO4ske8zFJumUvy-KqsCCoC95COqnuydCdtEl6pcEfb4YZEG-eiiqeqnp5quo1wVuCiXh32OY9RBcG8GEMw7qlGDdbLLaYikfVhjSyrRll5HG1wbhltWjJj4vqWUoHjDETgjytLkgjJN9xuql-f4UcwxC1BQQHbZZRZxc8CsYsMSHnUfmGbBjeom7JyGiPOkBzhAfwGSzq1mNT5wg6T2WEfrm8R_Me_DrOMcy6hNST8_AeXaMlBrv60hqU8mLX59WTXo8JXpzrZXV_--H7zaf67svHzzfXd7XZ4SbXwLju-57JruOaU8I049BxJozFHdWNxNjIHgvZEgBNJZWt3Jmm2wlhMeGGXVZvTndLop8LpKwmlwyMo_YQlqREyznlkhbw6gSaGFKK0Ks5uknHVRGsjvbVQf1rXx3tKyxUsV_WX57_LN0E9u_yWXcBXp2AXgelh-iSuv9GMWElJmvbhhXi9kRA8fHgIKpkHHgD1kUwWdng_i_LHzHCqzk</recordid><startdate>20081015</startdate><enddate>20081015</enddate><creator>Beaufays, F.</creator><creator>Onclin, K.</creator><creator>Verstegen, J.</creator><general>Elsevier Inc</general><general>[Oxford]: Butterworth-Heinemann; [New York]: Elsevier Science</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20081015</creationdate><title>Retrograde ejaculation occurs in the dog, but can be prevented by pre-treatment with phenylpropanolamine: A urodynamic study</title><author>Beaufays, F. ; Onclin, K. ; Verstegen, J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-e35afff37bb5a5213a35eb536cd0b2a8700c7f06791eea2727974c8b466d015c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adrenergic alpha-Agonists - pharmacology</topic><topic>Animals</topic><topic>bladder</topic><topic>Cross-Over Studies</topic><topic>Dog</topic><topic>dogs</topic><topic>Dogs - physiology</topic><topic>dosage</topic><topic>dose response</topic><topic>Dose-Response Relationship, Drug</topic><topic>Dose-titration study</topic><topic>drugs</topic><topic>ejaculation</topic><topic>Ejaculation - physiology</topic><topic>Male</topic><topic>male fertility</topic><topic>phenylpropanoids</topic><topic>Phenylpropanolamine</topic><topic>Phenylpropanolamine - pharmacology</topic><topic>Prostate - drug effects</topic><topic>Prostate - physiology</topic><topic>reproductive disorders</topic><topic>Retrograde ejaculation</topic><topic>Spermatozoa</topic><topic>urethra</topic><topic>Urethra - drug effects</topic><topic>Urethra - physiology</topic><topic>urine</topic><topic>Urodynamic</topic><topic>Urodynamics - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Beaufays, F.</creatorcontrib><creatorcontrib>Onclin, K.</creatorcontrib><creatorcontrib>Verstegen, J.</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Theriogenology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Beaufays, F.</au><au>Onclin, K.</au><au>Verstegen, J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Retrograde ejaculation occurs in the dog, but can be prevented by pre-treatment with phenylpropanolamine: A urodynamic study</atitle><jtitle>Theriogenology</jtitle><addtitle>Theriogenology</addtitle><date>2008-10-15</date><risdate>2008</risdate><volume>70</volume><issue>7</issue><spage>1057</spage><epage>1064</epage><pages>1057-1064</pages><issn>0093-691X</issn><eissn>1879-3231</eissn><abstract>Retrograde ejaculation is partial or total propulsion of semen from the posterior urethra into the urinary bladder; it is well characterized (and relatively common) in humans, with only a few reports in animals. Our objectives were to determine whether retrograde flow of semen occurred during ejaculation in mature dogs with normal fertility, and to determine the effects of phenylpropanolamine on this phenomenon (dose-titration, switch-back study). Retrograde ejaculation and urethral pressure profile measurements were evaluated (double-blind) in six dogs after 5 days of oral treatment with phenylpropanolamine (0, 2, 4, or 8 mg/kg); all dogs received all treatments (at 2-week intervals). The number of sperm in the urine was determined before and after each manual sperm collection. Urethral pressure profiles were obtained three times during each procedure. In the absence of phenylpropanolamine, sperm were present in the bladder after semen collection in all dogs (number varied significantly among individuals). The mean (±S.D.) number of sperm in the bladder was 17.0 ± 5.0, 18.5 ± 1.2, 5.1 ± 5.0, and 4.8 ± 0.1 × 10 6 sperm for 0, 2, 4, and 8 mg/kg, respectively (no significant difference between dogs given 4 or 8 mg/kg, but both were significantly lower than those given 0 or 2 mg/kg). This reduction was significantly correlated to the increase in mean urethral pressure at the level of the sphincter (39 cm versus 59 cm H 2O in placebo-treated dogs versus those given 8 mg/kg). In conclusion, we confirmed that retrograde ejaculation occurred during the ejaculatory process in normal dogs, and we demonstrated that phenylpropanolamine (4 or 8 mg/kg once daily for 5 days before collection) increased urethral pressure and reduced the number of sperm voided into the bladder during ejaculation.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>18675452</pmid><doi>10.1016/j.theriogenology.2008.06.026</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0093-691X
ispartof Theriogenology, 2008-10, Vol.70 (7), p.1057-1064
issn 0093-691X
1879-3231
language eng
recordid cdi_proquest_miscellaneous_69552572
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Adrenergic alpha-Agonists - pharmacology
Animals
bladder
Cross-Over Studies
Dog
dogs
Dogs - physiology
dosage
dose response
Dose-Response Relationship, Drug
Dose-titration study
drugs
ejaculation
Ejaculation - physiology
Male
male fertility
phenylpropanoids
Phenylpropanolamine
Phenylpropanolamine - pharmacology
Prostate - drug effects
Prostate - physiology
reproductive disorders
Retrograde ejaculation
Spermatozoa
urethra
Urethra - drug effects
Urethra - physiology
urine
Urodynamic
Urodynamics - drug effects
title Retrograde ejaculation occurs in the dog, but can be prevented by pre-treatment with phenylpropanolamine: A urodynamic study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T15%3A37%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Retrograde%20ejaculation%20occurs%20in%20the%20dog,%20but%20can%20be%20prevented%20by%20pre-treatment%20with%20phenylpropanolamine:%20A%20urodynamic%20study&rft.jtitle=Theriogenology&rft.au=Beaufays,%20F.&rft.date=2008-10-15&rft.volume=70&rft.issue=7&rft.spage=1057&rft.epage=1064&rft.pages=1057-1064&rft.issn=0093-691X&rft.eissn=1879-3231&rft_id=info:doi/10.1016/j.theriogenology.2008.06.026&rft_dat=%3Cproquest_cross%3E69552572%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69552572&rft_id=info:pmid/18675452&rft_els_id=S0093691X08003774&rfr_iscdi=true